We are live on ! Find out more
CNTB

Connect Biopharma Holdings
CNTB

26 hedge funds and large institutions have $285M invested in Connect Biopharma Holdings in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

27.57% more ownership

Funds ownership: 0% → 27.57% (+28%)

Holders
26
Holders Change
+26
Holders Change %
–
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$54.2M
2
RCM
RA Capital Management
Massachusetts
+$50.9M
3
BlackRock
BlackRock
New York
+$41.7M
4
BC
Boxer Capital
California
+$35.4M
5
CAM
Cormorant Asset Management
Massachusetts
+$17M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$58.9M +$54.2M +3,184,989 New
RCM
2
RA Capital Management
Massachusetts
$55.3M +$50.9M +2,991,208 New
BlackRock
3
BlackRock
New York
$45.3M +$41.7M +2,450,390 New
BC
4
Boxer Capital
California
$38.5M +$35.4M +2,081,323 New
CAM
5
Cormorant Asset Management
Massachusetts
$18.5M +$17M +1,000,000 New
Wellington Management Group
6
Wellington Management Group
Massachusetts
$17M +$15.6M +919,500 New
Janus Henderson Group
7
Janus Henderson Group
United Kingdom
$8.7M +$8.08M +475,000 New
RI
8
RTW Investments
New York
$8.32M +$7.66M +450,000 New
FCM
9
Farallon Capital Management
California
$7.4M +$6.81M +400,000 New
OCA
10
Octagon Capital Advisors
New York
$6.91M +$6.36M +373,492 New
Citadel Advisors
11
Citadel Advisors
Florida
$4.54M +$4.17M +245,191 New
LGM
12
Logos Global Management
California
$2.77M +$2.55M +150,000 New
RSCM
13
Rock Springs Capital Management
Maryland
$2.2M +$2.03M +119,114 New
MIM
14
Monashee Investment Management
Massachusetts
$2.04M +$1.87M +110,000 New
State of Wisconsin Investment Board
15
State of Wisconsin Investment Board
Wisconsin
$1.85M +$1.71M +100,272 New
HM
16
HealthCor Management
New York
$1.11M +$1.02M +60,000 New
MWNA
17
Marshall Wace North America
New York
$1.07M +$984K +57,824 New
Alyeska Investment Group
18
Alyeska Investment Group
Illinois
$925K +$851K +50,000 New
SFM
19
Sphera Funds Management
Israel
$925K +$851K +50,000 New
PCM
20
Pinz Capital Management
New York
$797K +$733K +43,100 New
Federated Hermes
21
Federated Hermes
Pennsylvania
$740K +$681K +40,000 New
Millennium Management
22
Millennium Management
New York
$205K +$189K +11,099 New
PHK
23
Point72 Hong Kong
Hong Kong
$193K +$177K +10,426 New
ZP
24
Zimmer Partners
New York
$185K +$170K +10,000 New
DCM
25
DAFNA Capital Management
California
$148K +$136K +8,000 New
1
2

CNTB Hedge Fund Activity: Q1 2021 in Review

26 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Connect Biopharma Holdings (CNTB) for Q1 2021, worth a combined $285M.

Buyers outnumbered sellers: 26 funds opened new CNTB positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $54.2M.

  • 26 institutional investors held Connect Biopharma Holdings (CNTB) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $285M of Connect Biopharma Holdings stock for Q1 2021.
  • 26 funds opened new Connect Biopharma Holdings positions in Q1 2021 and 0 closed out, a net change of +26 holders.
  • The largest Connect Biopharma Holdings buyer in Q1 2021 was Fidelity Investments, an estimated $54.2M added.

Based on aggregated 13F filings for Q1 2021.